Introduction

This EACR virtual event will be our first to offer proffered papers, poster spotlights, a virtual poster display and a panel discussion. We are excited to bring some of the networking and interactive elements that are a big part of EACR conferences to our online events as well as giving participants the chance to present their work.

Topics to be covered

The talks will aim to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.

Target audience

Translational scientists, biologists, geneticists, clinical chemists, molecular pathologists, oncologists, patient advocates, primary care (GPs), radiologists, clinical and non-clinical trainees, biotech and diagnostic companies, Pharma, bioengineers.

Scientific Programme Committee

• Alberto Bardelli, Italy (Chair)
• Carlos Caldas, UK
• Caroline Dive, UK
• Evi Lianidou, Greece
• Nickolas Papadopoulos, USA

Recordings

Please note that recordings from this conference will be available to all paying participants, at the discretion of each speaker.

Follow us on Twitter for updates @EACRnews and engage with the conference with #eacrLiquidBiopsies.

Contact

If you have any queries that are not answered on this webpage or in our FAQs, please contact us using the details below.

Claire Sullivan
Conference Officer
claire.sullivan@eacr.org